Eisai and Wren Therapeutics collaborate to target alpha-synuclein to treat synucleinopathies Nov. 30, 2020
FDA proposes conduct of additional exploratory analyses for omaveloxolone in Friedreich's ataxia Nov. 26, 2020
Clazosentan reduces all-cause morbidity and mortality post-aSAH in Japanese registration trials Nov. 24, 2020
RSS